Insights on reimbursement such as the variance of insurance coverage for DVT procedures across provinces and cities based on the type of insurance scheme are delved upon; one of the key findings is that although nearly 70-80% of DVT interventions are covered under public insurance, few patients opt for private insurances to increase coverage – are some of the unique insights covered only in this study.

Physician’s brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others affecting brand usage have been covered.

Future trends such as the introduction of new mechanical thrombectomy devices will shorten procedure durations and reduce out-of-pocket expenditure and healthcare expansion will drive volumes in the future.The coverage of competitor activities includes market events such as emerging companies, product approvals, clinical trials, partnerships, etc. Information on ongoing clinical trials by domestic companies like the SaExten IVCF System in Prevention of PE by ShenZhen KYD Biomedical Technology Co., Ltd and new product developments and acquisitions by key players like Boston Scientific, Cook Medical, Philips Healthcare, and Invamed are covered in the report.